An Overview of Novel Coronavirus SARS-Cov-2 Spanning around the Past, Present and Future Perspectives

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), a new enveloped RNA virus known as Coronavirus (COVID-19) are most prevalent in humans and wild animals. All four species that is alpha, beta, delta and theta have been identified till date and are responsible for human disease; causin...

Full description

Bibliographic Details
Main Authors: Shadma Yaqoob, Areena H. Siddiqui, R. Harsvardhan, J. Ahmad, V.K. Srivastava, M.K. Verma, P. Verma, A.N. Singh
Format: Article
Language:English
Published: Journal of Pure and Applied Microbiology 2020-05-01
Series:Journal of Pure and Applied Microbiology
Subjects:
Online Access:https://microbiologyjournal.org/an-overview-of-novel-coronavirus-sars-cov-2-spanning-around-the-past-present-and-future-perspectives/
_version_ 1811191491061612544
author Shadma Yaqoob
Areena H. Siddiqui
R. Harsvardhan
J. Ahmad
V.K. Srivastava
M.K. Verma
P. Verma
A.N. Singh
author_facet Shadma Yaqoob
Areena H. Siddiqui
R. Harsvardhan
J. Ahmad
V.K. Srivastava
M.K. Verma
P. Verma
A.N. Singh
author_sort Shadma Yaqoob
collection DOAJ
description Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), a new enveloped RNA virus known as Coronavirus (COVID-19) are most prevalent in humans and wild animals. All four species that is alpha, beta, delta and theta have been identified till date and are responsible for human disease; causing influenza like illness (ILI). This virus has similar lineage of Middle East Respiratory Syndrome coronavirus (MERS-CoV) and related Coronavirus (SARS-CoV). This outbreak initially presented as pneumonia-like illness in a group of people in Wuhan, China. The infection was said to be caused by seafood and unusual animals in the wholesale markets of this city. SARS-CoV-2 is highly infectious and has resulted in a rapid pandemic. As of now it has spread to 197 countries with total no of cases in the world being 3.76 million as of early march. The mortality till now is 7.11% . The cases have been increasing since its first discovery in China. In India also the number has been increased. Till now India has total of 39,980 cases and mortality is attributed to be 3.26%. As per data from Ministry of health and family welfare (MoHFW) death is more commonly seen in males with age >60years. Among these most of the deaths were related to other co-morbid conditions. This article will help the readers with an overview of novel Coronavirus spanning around the clinical features, diagnostic modalities, treatment strategies and infection control measures. It will also help in raising awareness among healthcare workers regarding COVID-19 and aid in early recognition of these patients. Moreover, this review will also focus on the most recent information for the effective management, prevention, and treatment of patients worldwide.
first_indexed 2024-04-11T15:05:47Z
format Article
id doaj.art-0be37a4bd41f47ae8113b2a1069d1606
institution Directory Open Access Journal
issn 0973-7510
2581-690X
language English
last_indexed 2024-04-11T15:05:47Z
publishDate 2020-05-01
publisher Journal of Pure and Applied Microbiology
record_format Article
series Journal of Pure and Applied Microbiology
spelling doaj.art-0be37a4bd41f47ae8113b2a1069d16062022-12-22T04:16:48ZengJournal of Pure and Applied MicrobiologyJournal of Pure and Applied Microbiology0973-75102581-690X2020-05-0114suppl 177578810.22207/JPAM.14.SPL1.15An Overview of Novel Coronavirus SARS-Cov-2 Spanning around the Past, Present and Future PerspectivesShadma Yaqoob0Areena H. Siddiqui1https://orcid.org/0000-0002-2524-1711R. Harsvardhan2J. Ahmad3V.K. Srivastava4M.K. Verma5https://orcid.org/0000-0003-2618-4277P. Verma6https://orcid.org/0000-0002-1316-9812A.N. Singh7https://orcid.org/0000-0002-6935-2763Department of Microbiology, Era’s Medical College and Hospital, Lucknow - 226 003, India.Department of Lab Medicine, Sahara Hospital, Lucknow - 226 010, India.Department of Hospital Administration, Sanjay Gandhi Post Graduate Institute, Lucknow - 226 014, India.Department of Pharmacology, BRD Medical College, Gorakhpur - 273 013, India.Lab Director, Cadmus Clinical Laboratories, Lucknow - 226 013, India.Department of Biochemistry, G.S.V.M. Medical College, Kanpur - 208 002, India.Department of Biotechnology, IFTM University, Moradabad - 244 001, India. Department of Biochemistry, G.S.V.M. Medical College, Kanpur - 208 002, India.Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), a new enveloped RNA virus known as Coronavirus (COVID-19) are most prevalent in humans and wild animals. All four species that is alpha, beta, delta and theta have been identified till date and are responsible for human disease; causing influenza like illness (ILI). This virus has similar lineage of Middle East Respiratory Syndrome coronavirus (MERS-CoV) and related Coronavirus (SARS-CoV). This outbreak initially presented as pneumonia-like illness in a group of people in Wuhan, China. The infection was said to be caused by seafood and unusual animals in the wholesale markets of this city. SARS-CoV-2 is highly infectious and has resulted in a rapid pandemic. As of now it has spread to 197 countries with total no of cases in the world being 3.76 million as of early march. The mortality till now is 7.11% . The cases have been increasing since its first discovery in China. In India also the number has been increased. Till now India has total of 39,980 cases and mortality is attributed to be 3.26%. As per data from Ministry of health and family welfare (MoHFW) death is more commonly seen in males with age >60years. Among these most of the deaths were related to other co-morbid conditions. This article will help the readers with an overview of novel Coronavirus spanning around the clinical features, diagnostic modalities, treatment strategies and infection control measures. It will also help in raising awareness among healthcare workers regarding COVID-19 and aid in early recognition of these patients. Moreover, this review will also focus on the most recent information for the effective management, prevention, and treatment of patients worldwide.https://microbiologyjournal.org/an-overview-of-novel-coronavirus-sars-cov-2-spanning-around-the-past-present-and-future-perspectives/covid-19pandemicimmunoinformaticsmers covresiliencesars cov-2
spellingShingle Shadma Yaqoob
Areena H. Siddiqui
R. Harsvardhan
J. Ahmad
V.K. Srivastava
M.K. Verma
P. Verma
A.N. Singh
An Overview of Novel Coronavirus SARS-Cov-2 Spanning around the Past, Present and Future Perspectives
Journal of Pure and Applied Microbiology
covid-19
pandemic
immunoinformatics
mers cov
resilience
sars cov-2
title An Overview of Novel Coronavirus SARS-Cov-2 Spanning around the Past, Present and Future Perspectives
title_full An Overview of Novel Coronavirus SARS-Cov-2 Spanning around the Past, Present and Future Perspectives
title_fullStr An Overview of Novel Coronavirus SARS-Cov-2 Spanning around the Past, Present and Future Perspectives
title_full_unstemmed An Overview of Novel Coronavirus SARS-Cov-2 Spanning around the Past, Present and Future Perspectives
title_short An Overview of Novel Coronavirus SARS-Cov-2 Spanning around the Past, Present and Future Perspectives
title_sort overview of novel coronavirus sars cov 2 spanning around the past present and future perspectives
topic covid-19
pandemic
immunoinformatics
mers cov
resilience
sars cov-2
url https://microbiologyjournal.org/an-overview-of-novel-coronavirus-sars-cov-2-spanning-around-the-past-present-and-future-perspectives/
work_keys_str_mv AT shadmayaqoob anoverviewofnovelcoronavirussarscov2spanningaroundthepastpresentandfutureperspectives
AT areenahsiddiqui anoverviewofnovelcoronavirussarscov2spanningaroundthepastpresentandfutureperspectives
AT rharsvardhan anoverviewofnovelcoronavirussarscov2spanningaroundthepastpresentandfutureperspectives
AT jahmad anoverviewofnovelcoronavirussarscov2spanningaroundthepastpresentandfutureperspectives
AT vksrivastava anoverviewofnovelcoronavirussarscov2spanningaroundthepastpresentandfutureperspectives
AT mkverma anoverviewofnovelcoronavirussarscov2spanningaroundthepastpresentandfutureperspectives
AT pverma anoverviewofnovelcoronavirussarscov2spanningaroundthepastpresentandfutureperspectives
AT ansingh anoverviewofnovelcoronavirussarscov2spanningaroundthepastpresentandfutureperspectives
AT shadmayaqoob overviewofnovelcoronavirussarscov2spanningaroundthepastpresentandfutureperspectives
AT areenahsiddiqui overviewofnovelcoronavirussarscov2spanningaroundthepastpresentandfutureperspectives
AT rharsvardhan overviewofnovelcoronavirussarscov2spanningaroundthepastpresentandfutureperspectives
AT jahmad overviewofnovelcoronavirussarscov2spanningaroundthepastpresentandfutureperspectives
AT vksrivastava overviewofnovelcoronavirussarscov2spanningaroundthepastpresentandfutureperspectives
AT mkverma overviewofnovelcoronavirussarscov2spanningaroundthepastpresentandfutureperspectives
AT pverma overviewofnovelcoronavirussarscov2spanningaroundthepastpresentandfutureperspectives
AT ansingh overviewofnovelcoronavirussarscov2spanningaroundthepastpresentandfutureperspectives